Propanc Biopharma (PPCB) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Propanc Biopharma (PPCB) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Propanc Biopharma

· PPCB

Dashboard

Financials

Ratios

Valuation

Statistics

3.213 M

-1.48%

General

Market Cap: $3.21M
Enterprise Value: $816.3K
Shares Outstanding: 2,280,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -147.60%
ROE: -167.51%
ROIC: -183.49%
Current Ratio: 2.55
Debt-to-Equity: 0.05
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 0.12
EV/EBITDA: -0.05

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $18.18M
Operating Income: -$18.19M
Net Profit: -$18.86M

Balance Sheet

Cash and Equivalents: $832.01K
Working Capital: $5.19M
Total Assets: $12.78M
Net Debt: -$322.89K
Total Liabilities: $3.38M
Total Equity: $9.4M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$5.79M
Cash Flow from Investing: -$4.97K
Cash Flow from Financing: $6.58M
Free Cash Flow: -$5.79M
Capital Expenditures: $51